News
The Food and Drug Administration (FDA) has cleared Lumipulse G for U.S. commercialization as the first blood-based test that ...
The FDA has cleared the first-ever blood test for early Alzheimer's detection, which the agency says reduces the need for ...
The Food and Drug Administration cleared a new kind of test for Alzheimer’s disease designed to be more accessible and less ...
The FDA has approved the Lumipulse Plasma Ratio test, a groundbreaking blood test for early dementia detection. This less ...
Japan-based Fujirebio's test, which helps doctors diagnose Alzheimer's disease, is intended for patients with signs of ...
The Food and Drug Administration (FDA) announced Friday it had cleared a new test to help diagnose adults with Alzheimer’s ...
The U.S. Food and Drug Administration on Friday approved a new blood test for the early detection of Alzheimer's disease in ...
The FDA said it has issued its first official green light for a blood test to help diagnose Alzheimer’s disease, adding that ...
Today, the FDA's approved the Lumipulse G pTau217/β-Amyloid 1-42 Plasma Ratio, marking a pivotal moment in the fight against ...
The US Food and Drug Administration has given marketing clearance to a blood test to help diagnose Alzheimer’s disease, ...
There's a new way to screen for early detection of Alzheimer's disease. On Friday, the Food and Drug Administration (FDA) ...
The Lumipulse G pTau217/Beta-Amyloid 1-42 Plasma Ratio is for the early detection of amyloid plaques associated with Alzheimer’s disease in symptomatic adults 55 years and older.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results